✦ LIBER ✦

BLEEDING WITH ASPIRIN AND APIXABAN IN PATIENTS UNSUITABLE FOR VITAMIN K ANTAGONIST THERAPY: THE AVERROES STUDY

✍ Scribed by Greg C. Flaker; John Eikelboom; Stuart Connolly; Salim Yusuf; Gregory Lip; Robert Hart

Book ID: 118582382
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 90 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(12)60573-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding During Treatment With Aspirin V

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial

✍ Flaker, G. C.; Eikelboom, J. W.; Shestakovska, O.; Connolly, S. J.; Kaatz, S.; B 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 850 KB

Rationale and design of AVERROES: Apixab

Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

✍ John W. Eikelboom; Martin O'Donnell; Salim Yusuf; Rafael Diaz; Greg Flaker; Robe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Spontaneous and non-spontaneous bleeding

Spontaneous and non-spontaneous bleeding complications in patients with oral vitamin K antagonist therapy

✍ Hoffmann, Martin; Zimmermann, Markus; Meyer, Rüdiger; Laubert, Tilman; Begum, Ne 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 432 KB

DUAL ANTIPLATELET THERAPY OR APIXABAN IN

DUAL ANTIPLATELET THERAPY OR APIXABAN IN PATIENTS INELIGIBLE FOR VITAMIN-K ANTAGONISTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: LESSONS FROM THE RECENT ASPIRIN-CONTROLLED TRIALS

✍ Jeroen Jaspers Focks; Marc A. Brouwer; Freek W.A. Verheugt 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 193 KB

The risk of bleeding of triple therapy w

The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions

✍ Andrea, Rubboli 📂 Article 📅 2012 🏛 China Science Publishing & Media Ltd. 🌐 Chinese ⚖ 159 KB

Triple Therapy With Aspirin, Prasugrel,

Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation

✍ Sarafoff, Nikolaus; Martischnig, Amadea; Wealer, Jill; Mayer, Katharina; Mehilli 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 528 KB